E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases

The Journal of Biological Chemistry
Isai Pratha KarthikSundarasamy Mahalingam

Abstract

RAS proteins are major human oncogenes, and most of the studies are focused on enzymatic RAS effectors. Recently, nonenzymatic RAS effectors (RASSF, RAS association domain family) have garnered special attention because of their tumor-suppressive properties in contrast to the oncogenic potential of the classical enzymatic RAS effectors. Whereas most members of RASSF family are deregulated by promoter hypermethylation, RASSF8 promoter remains unmethylated in many cancers but the mechanism(s) of its down-regulation remains unknown. Here, we unveil E4BP4 as a critical transcriptional modulator repressing RASSF8 expression through histone methyltransferases, G9a and SUV39H1. In line with these observations, we noticed a negative correlation of RASSF8 and E4BP4 expression in primary breast tumor samples. In addition, our data provide evidence that E4BP4 attenuates RASSF8-mediated anti-proliferation and apoptosis, shedding mechanistic insights into RASSF8 down-regulation in breast cancers. Collectively, our study provides a better understanding on the epigenetic regulation of RASSF8 function and implicates the development of better treatment strategies.

References

Jun 22, 2000·Analytical Biochemistry·B W DyerR Rodriguez
Nov 10, 2001·Science·I R Vetter, A Wittinghofer
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
May 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·V G ALLFREYA E MIRSKY
Dec 5, 2003·Current Biology : CB·Hartmut Scheel, Kay Hofmann
Feb 8, 2006·Oncogene·F S FalvellaT A Dragani
Nov 7, 2006·Genes & Development·Pierre-Olivier EstèveSriharsa Pradhan
Apr 13, 2007·Biochimica Et Biophysica Acta·Krishnaraj RajalingamStefan Albert
Apr 7, 2009·Biochimica Et Biophysica Acta·Antje M RichterReinhard H Dammann
Sep 29, 2009·Nature·Mark A DawsonTony Kouzarides
Dec 17, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Harold D MacGillavryRonald E van Kesteren
Feb 27, 2010·Molecular and Cellular Biochemistry·Yi-Jiun WengKwong-Chung Tung
Jun 16, 2010·The Journal of Biological Chemistry·Arunkumar DhayalanAlbert Jeltsch
Apr 19, 2011·Genes & Development·Yoichi Shinkai, Makoto Tachibana
Jun 23, 2011·Cancer Informatics·Gwangsik ShinSeon-Young Kim
Nov 25, 2011·Methods in Molecular Biology·Padmaja Gade, Dhan V Kalvakolanu
Jan 30, 2013·Advances in Biological Regulation·Jia Jia ChanMatilda Katan
May 1, 2013·Genes & Development·Megan KeniryRamon Parsons
Mar 13, 2014·FEBS Letters·Natalia VolodkoShairaz Baksh
May 23, 2014·International Journal of Cancer. Journal International Du Cancer·Tetsuhiro ChibaOsamu Yokosuka
Mar 10, 2015·Frontiers in Endocrinology·Antje M RichterReinhard H Dammann
Mar 31, 2015·Database : the Journal of Biological Databases and Curation·Quan WanRaja Mazumder

❮ Previous
Next ❯

Citations

Aug 25, 2018·The Journal of Biological Chemistry·Anbarasu KumaraswamySundarasamy Mahalingam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.